EMA under attack again over document disclosure
This article was originally published in SRA
Executive Summary
Despite its renewed efforts to publish more clinical trial data, the European Medicines Agency has again come under attack by the independent French drug bulletin, Prescrire, for refusing to disclose clinical trial and other information on two medicines1.